About this item:

107 Views | 50 Downloads

Author Notes:

hnakshat@iupui.edu

CS performed the analysis of cell lines for stem cell phenotype, Northern analysis, intracardiac injection, and necropsy of animals. HK performed intracardiac injection and trained others in this technique. RF and CHT conducted imaging studies.

SM and SB were responsible for histology. PBN conducted Northern analysis and invasion assays. RG was involved in procuring primary tumor samples that were analyzed in parallel with cell lines. HN was involved in designing all experiments, performing flow cytometry, and writing the manuscript.

We thank Dr YC Yang for IL-11 cDNA, and SE Rice for assistance in flow cytometry. We thank Drs Edward Chen, Daniela Matei, and David Donner for critical reading of this manuscript.

The authors declare that they have no competing interests.

Subjects:

Research Funding:

This work was supported by the grants from the American Institute for Cancer Research (03A069-REN), the National Cancer Institute (R01-CA89153) and Indiana University Cancer Center Pilot Grant (to HN). HN is Marian J Morrison Investigator in Breast Cancer Research.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • ESTROGEN-RECEPTOR
  • BONE METASTASIS
  • MAMMARY-GLAND
  • EXPRESSION
  • LINES
  • ACTIVATION
  • MIGRATION
  • TUMORS
  • PROGRESSION
  • VIMENTIN

CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

Tools:

Journal Title:

BREAST CANCER RESEARCH

Volume:

Volume 8, Number 5

Publisher:

, Pages R59-R59

Type of Work:

Article | Final Publisher PDF

Abstract:

Introduction: A subpopulation (CD44+/CD24-) of breast cancer cells has been reported to have stem/progenitor cell properties. The aim of this study was to investigate whether this subpopulation of cancer cells has the unique ability to invade, home, and proliferate at sites of metastasis. Methods: CD44 and CD24 expression was determined by flow cytometry. Northern blotting was used to determine the expression of proinvasive and 'bone and lung metastasis signature' genes. A matrigel invasion assay and intracardiac inoculation into nude mice were used to evaluate invasion, and homing and proliferation at sites of metastasis, respectively. Results: Five among 13 breast cancer cell lines examined (MDA-MB-231, MDA-MB-436, Hs578T, SUM1315, and HBL-100) contained a higher percentage (>30%) of CD44+/CD24- cells. Cell lines with high CD44+/CD24- cell numbers express basal/ mesenchymal or myoepithelial but not luminal markers. Expression levels of proinvasive genes (IL-1α, IL-6, IL-8, and urokinase plasminogen activator [UPA]) were higher in cell lines with a significant CD44+/CD24- population than in other cell lines. Among the CD44+/CD24--positive cell lines, MDA-MB-231 has the unique property of expressing a broad range of genes that favor bone and lung metastasis. Consistent with previous studies in nude mice, cell lines with CD44+/ CD24- subpopulation were more invasive than other cell lines. However, only a subset of CD44+/CD24--positive cell lines was able to home and proliferate in lungs. Conclusion: Breast cancer cells with CD44+/CD24- subpopulation express higher levels of proinvasive genes and have highly invasive properties. However, this phenotype is not sufficient to predict capacity for pulmonary metastasis. © 2006 Sheridan et al., licensee BioMed Central Ltd.

Copyright information:

© 2006 Sheridan et al.; licensee BioMed Central Ltd.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 2.0 Generic License (https://creativecommons.org/licenses/by/2.0/).
Export to EndNote